Toward imaging biomarkers for osteoarthritis

被引:62
作者
Gray, ML
Eckstein, F
Peterfy, C
Dahlberg, L
Kim, YJ
Sorensen, AG
机构
[1] Harvard Univ, Sch Med, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA
[2] New England Baptist Bone & Joint Inst, Boston, MA USA
[3] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA
[4] Univ Munich, Inst Anat, Munich, Germany
[5] Synarc Corp, San Francisco, CA USA
[6] Univ Hosp, Dept Orthoped, Malmo, Sweden
[7] Childrens Hosp, Dept Orthoped, Boston, MA USA
[8] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA
关键词
D O I
10.1097/01.blo.0000144972.50849.d9
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Many new therapeutic strategies have been and are being developed to correct, prevent, or slow the progression of osteoarthritis. Our ability to evaluate the efficacy of these techniques, or to determine the situations for which they might provide the most benefit, critically depends on diagnostic measures that can serve as proxies for the present or predicted state of the cartilage. Many of the magnetic resonance imaging techniques that have been emerging over the past decades appear promising in that they have shown technical validity in measuring the morphologic and molecular state of cartilage. With continued development and added insight from pilot clinical studies, these or related methods may soon be in customary use. These techniques are part of a paradigm shift where therapeutic strategies are developed hand-in-hand with diagnostic approaches-a shift that offers the promise of speeding development of effective therapies, and focusing their use in areas where they can be most successful.
引用
收藏
页码:S175 / S181
页数:7
相关论文
共 79 条
  • [1] Glycosaminoglycan in articular cartilage: In vivo assessment with delayed Gd(DTPA)(2-)-enhanced MR imaging
    Bashir, A
    Gray, ML
    Boutin, RD
    Burstein, D
    [J]. RADIOLOGY, 1997, 205 (02) : 551 - 558
  • [2] Bashir A, 1999, MAGNET RESON MED, V41, P857, DOI 10.1002/(SICI)1522-2594(199905)41:5<857::AID-MRM1>3.0.CO
  • [3] 2-E
  • [4] Gd-DTPA(2-) as a measure of cartilage degradation
    Bashir, A
    Gray, ML
    Burstein, D
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1996, 36 (05) : 665 - 673
  • [5] Bashir A, 1995, THESIS MIT
  • [6] A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
    Bathon, JM
    Martin, RW
    Fleischmann, RM
    Tesser, JR
    Schiff, MH
    Keystone, EC
    Genovese, MC
    Wasko, MC
    Moreland, LW
    Weaver, AL
    Markenson, J
    Finck, BK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) : 1586 - 1593
  • [7] Risk factors for progressive cartilage loss in the knee
    Biswal, S
    Hastie, T
    Andriacchi, TP
    Bergman, GA
    Dillingham, MF
    Lang, P
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (11): : 2884 - 2892
  • [8] Accuracy of T2-weighted fast spin-echo MR imaging with fat saturation in detecting cartilage defects in the knee: Comparison with arthroscopy in 130 patients
    Bredella, MA
    Tirman, PFJ
    Peterfy, CG
    Zarlingo, M
    Feller, JF
    Bost, FW
    Belzer, JP
    Wischer, TK
    Genant, HK
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 172 (04) : 1073 - 1080
  • [9] SEVERITY OF ARTICULAR-CARTILAGE ABNORMALITY IN PATIENTS WITH OSTEOARTHRITIS - EVALUATION WITH FAST SPIN-ECHO MR VS ARTHROSCOPY
    BRODERICK, LS
    TURNER, DA
    RENFREW, DL
    SCHNITZER, TJ
    HUFF, JP
    HARRIS, C
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 162 (01) : 99 - 103
  • [10] Feasibility of T and Z scores from magnetic resonance imaging data for quantification of cartilage loss in osteoarthritis
    Burgkart, R
    Glaser, C
    Hinterwimmer, S
    Hudelmaier, M
    Englmeier, KH
    Reiser, M
    Eckstein, F
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (10): : 2829 - 2835